Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer

Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer

Abstract Introduction To confirm the feasibility of hypofractionated proton beam therapy (PBT), we compared the acute adverse event rates and International Prostate Symptom Score (IPSS) in prostate cancer patients treated with hypofractionated versus conventionally fractionated (2.0 Gy relative biol...

Full description

Bibliographic Details
Main Authors: Takashi Iizumi, Hitoshi Ishikawa, Yuta Sekino, Keiichi Tanaka, Daichi Takizawa, Hirokazu Makishima, Haruko Numajiri, Masashi Mizumoto, Kei Nakai, Toshiyuki Okumura, Hideyuki Sakurai
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Journal of Medical Radiation Sciences
Subjects:
acute toxicity
hypofractionation
patient‐reported outcome measures
prostate cancer
proton beam
Online Access:https://doi.org/10.1002/jmrs.551

Internet

https://doi.org/10.1002/jmrs.551

Similar Items